Prnewswireยท2025-08-20 21:56Core Viewpoint - Centene Corporation received an unsolicited "mini-tender" offer from TRC Capital Investment Corporation to purchase up to 4 million shares at $24.75 per share, which is below the current market price [1][2] Group 1: Company Response - Centene recommends that stockholders reject TRC's offer and evaluate the current market price of their shares, advising consultation with financial advisors [2] - The company urges investors to be cautious with mini-tender offers, as they may lead to selling securities at below-market prices [2] Group 2: Offer Details - TRC's offer is set to expire on September 4th, 2025, and may be extended [1] - Investors who have already tendered their shares can withdraw them by providing written notice before the expiration of the offer [3] Group 3: Company Overview - Centene Corporation is a Fortune 500 company focused on providing integrated healthcare services, particularly to under-insured and uninsured individuals [4] - The company serves over 1 in 15 individuals in the U.S., including Medicaid and Medicare members, and offers affordable healthcare products [4]